Free Trial

CoreWeave Inc. (NASDAQ:CRWV) Receives Average Recommendation of "Hold" from Brokerages

CoreWeave logo with Computer and Technology background

Shares of CoreWeave Inc. (NASDAQ:CRWV - Get Free Report) have received a consensus rating of "Hold" from the twenty-nine analysts that are presently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, fourteen have issued a hold recommendation, eleven have given a buy recommendation and two have given a strong buy recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $114.16.

CRWV has been the topic of several analyst reports. Hsbc Global Res raised shares of CoreWeave to a "moderate sell" rating in a research report on Thursday, July 17th. Arete Research raised CoreWeave from a "hold" rating to a "strong-buy" rating in a research report on Thursday, August 21st. Moffett Nathanson boosted their target price on CoreWeave from $56.00 to $65.00 and gave the company a "neutral" rating in a research report on Tuesday, August 19th. Mizuho reissued a "neutral" rating and issued a $150.00 target price (up previously from $70.00) on shares of CoreWeave in a research report on Tuesday, July 8th. Finally, Northland Securities boosted their target price on CoreWeave from $85.00 to $165.00 and gave the company an "outperform" rating in a research report on Friday, July 18th.

Read Our Latest Report on CoreWeave

CoreWeave Stock Up 0.4%

CRWV stock opened at $121.39 on Friday. The company has a debt-to-equity ratio of 2.79, a quick ratio of 0.52 and a current ratio of 0.52. The firm's 50 day moving average price is $111.41. CoreWeave has a one year low of $33.51 and a one year high of $187.00.

CoreWeave (NASDAQ:CRWV - Get Free Report) last released its quarterly earnings results on Tuesday, August 12th. The company reported ($0.27) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.07). The firm had revenue of $1.21 million for the quarter. The company's revenue was up 206.7% compared to the same quarter last year. CoreWeave has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS.

Insider Buying and Selling at CoreWeave

In other CoreWeave news, major shareholder Magnetar Financial Llc sold 211,835 shares of the business's stock in a transaction that occurred on Wednesday, September 17th. The stock was sold at an average price of $120.09, for a total value of $25,439,265.15. Following the sale, the insider owned 1,113,425 shares of the company's stock, valued at $133,711,208.25. The trade was a 15.98% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Nitin Agrawal sold 38,422 shares of the business's stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $118.18, for a total value of $4,540,711.96. Following the completion of the sale, the chief financial officer directly owned 145,588 shares in the company, valued at approximately $17,205,589.84. The trade was a 20.88% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 12,775,454 shares of company stock valued at $1,334,210,633 over the last quarter.

Hedge Funds Weigh In On CoreWeave

Several institutional investors have recently modified their holdings of the business. Nvidia Corp grew its stake in shares of CoreWeave by 0.4% in the second quarter. Nvidia Corp now owns 24,277,573 shares of the company's stock worth $3,958,701,000 after acquiring an additional 95,113 shares in the last quarter. Cisco Systems Inc. acquired a new position in shares of CoreWeave in the second quarter worth $173,493,000. Geode Capital Management LLC grew its stake in shares of CoreWeave by 142.6% in the second quarter. Geode Capital Management LLC now owns 716,178 shares of the company's stock worth $116,809,000 after acquiring an additional 420,915 shares in the last quarter. Lmdagg L.L.C. acquired a new position in shares of CoreWeave in the second quarter worth $48,030,000. Finally, Sivia Capital Partners LLC acquired a new position in shares of CoreWeave in the second quarter worth $39,824,000.

CoreWeave Company Profile

(Get Free Report)

CoreWeave, Inc engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

Featured Stories

Analyst Recommendations for CoreWeave (NASDAQ:CRWV)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CoreWeave Right Now?

Before you consider CoreWeave, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CoreWeave wasn't on the list.

While CoreWeave currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.